-
A prescription for a drug called Kerydin depleted one woman's health reimbursement account without her even knowing it. When should health care providers broach costs with patients?
-
The Pharmaceutical Research and Manufacturers of America, the brand-name drug industry's main trade group, spent liberally to shift the conversation on prices during the last presidential campaign.
-
A bill passed by the California Legislature requires drugmakers to give 60 days' notice before raising a drug's price by 16 percent or more over two years, and to justify the price increase.
-
Doctors were more likely to choose generic drugs over pricier brand names when teaching hospitals limited access by pharmaceutical sales representatives, a study finds.
-
A spokesman said Tuesday that President Trump does want Medicare to be able to directly negotiate prescription drug prices with drugmakers. Analysts disagree about how much difference that would make.
-
Lawmakers are demanding answers as to why the price of EpiPens, which are used to stop life-threatening allergic reaction, keeps going up. The company said Thursday it will reimburse some of the cost.
-
Researchers found that in states with medical marijuana laws on the books, the number of prescriptions dropped for drugs to treat anxiety, depression, nausea, pain, seizures and sleep disorders.